CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 16,077 shares, a drop of 75.9% from the May 31st total of 66,704 shares. Based on an average daily volume of 219,950 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.
Analyst Ratings Changes
A number of research firms have recently commented on CHEOY. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. UBS Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Report on CHEOY
CochLear Price Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
- Five stocks we like better than CochLear
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
